πŸ‡ΊπŸ‡Έ FDA
Patent

US 9018374

Crystal of amide compound

granted A61KA61K31/5377A61P

Quick answer

US patent 9018374 (Crystal of amide compound) held by Takeda Pharmaceutical Company Limited expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/5377, A61P, A61P13/12, A61P43/00